ResMed RMD has outperformed the market over the past 10 years by 2.93% on an annualized basis producing an average annual return of 13.86%. Currently, ResMed has a market capitalization of $34.51 ...

Goldman Sachs analyst Davinthra Thillainathan maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ...

ResMed formed a double-bottom base with a 252.36 buy point, beginning last October. It topped the buy point at the end of January but quickly faded from that point amid overall ma ...

The stock's fall snapped a two-day winning streak. ResMed Inc. closed 10.21% short of its 52-week high of $263.05, which the company reached on January 30th. Trading volume (2.6 M) eclipsed its 50 ...

ResMed's 10.2% revenue jump in Q2 was driven by strong demand for sleep health products, with a particular focus on expansion in digital health platforms. The 29.3% year-over-year bump up in ...

Shares of ResMed Inc. RMD rallied 1.80% to $236.63 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

7 out of 10 employed respondents have called in sick at least once ... SAN DIEGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), a global health technology leader focused on sleep, ...

ResMed's fifth annual Global Sleep Survey highlights ... and 374 decrease their positions in their most recent quarter. 7 out of 10 employed respondents have called in sick at least once in ...

Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to EveryoneSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...